Yunmeng Liu, Ph.D.Yunmeng Liu, Ph.D.

Ph.D., New York Medical College, Valhalla, NY,  2013
Dr. Liu is a member of the Rusch Lab. She has many years of experience in molecular biology & physiology. Her research interest focuses on the molecular mechanism of pathogenesis of hypertension, in particular, salt-sensitive hypertension. Dr. Liu’s current working project involves collaboration with Dr. Mu, exploring the role of immune cells in impairing sodium-handling in the kidney, which leads to salt-retention and the development of salt-sensitive hypertension. Their work has recently been awarded by the American Heart Association.

Selected Publication(s):

Liu Y, Rafferty T, Rhee S, Webber J, Song L, Ko B, Hoover R, He B, Mu S. CD8+ T cells stimulate Na-Cl co-transporter NCC in distal convoluted tubules leading to salt-sensitive hypertension. Nat. Commun. 8, 10437; 2017 (PMID: 28067240).
Pan X, Liao Y, Liu Y, Chang, P, Liao L, Yang L, Hongquan L. Transcription of AAT•ATT Triplet Repeats in Escherichia coli is silenced by H-NS and IS1E Transposition.  PLoS One. 5(12), 2010 (PMID:21151567).

Michael Berquist II, Ph.D.Michael Berquist II, Ph.D.

Ph.D., Western Michigan University, Kalamazoo, MI, 2016

Michael is a post-doctoral trainee working under the NIDA T32 Translational Training in Addiction grant (Director: Clint Kilts, Ph.D.). He is jointly mentored by Dr. William Fantegrossi and Dr. Michael Owens in the Department of Pharmacology and Toxicology. He is primarily interested in investigating the in vivo effects of psychoactive substances using a variety of preclinical experimental procedures and in determining the behavioral effects of drug mixtures. With a strong background in behavioral statistics and experimental design, Michael also enjoys exploring novel data path analyses for psychopharmacological experiments.

Selected Publication(s):
Berquist II MD, Traxler HK, Mahler AM, Baker LE. Behavioral sensitization to the hyperlocomotor effects of “bath salt” mixtures, 4-methylmethcathinone (4-MMC) and 3, 4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats. Drug and Alcohol Dependence. 16:128-134, 2016 (PMID: 27181413).

Berquist II MD, Peet NM, Baker LE. Behavioral sensitization following concurrent exposure to mephedrone and d-amphetamine in female mice. Behavioural Pharmacology. 26:180-183, 2015 (PMID: 25485643).

Mousumi Patra, Ph.DMousumi Patra, Ph.D

Ph.D., University of Kalyani, West Bengal, India, 2018

Dr. Patra studied the synthesis and characterization of calcium phosphate flavonoid nano-composite and its protective role against oxidative stress.

Her   research is focused on understanding the mechanism of neurodegeneration in amyotrophic lateral sclerosis (ALS) and to develop novel therapeutic strategies for this disease.  Currently, she is working on a project aiming to develop strategies to inhibit mutant profilin1 (PFN1) protein aggregation which causes ALS in mice and human.

Selected Publication(s):

Mousumi P, Riya M, Milon B, Debanjan D, Naznin AB, Tarakdas B. Calcium Phosphate-Quercetin Nanocomposite (CPQN): A multi-functional nanoparticle having pH indicating, highly fluorescent and anti-oxidant properties. Colloids and Surfaces B: Biointerfaces 154 (2017) 63-73

Riya M, Mousumi P, Debanjan D, Milon B, Tarakdas B. Tetracycline-loaded calcium phosphate nanoparticle (Tet-CPNP):Rejuvenation of an obsolete antibiotic to further action, Biochimica et Biophysica Acta, 1860 (2016) 1929–1941

Milon B, Mousumi P, Debanjan D, Riya MTB. A simple robust method of synthesis of copper–silver core–shell nano-particle: evaluation of its structural and chemical properties with anticancer potency. Nanotechnology, 29 (2018)